Id-like reaction to BCG therapy for bladder cancer

Christopher Lowther, John D. Miedler, Clay J. Cockerell

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Id reaction, also known as autoeczematization, is the development of dermatitis that is distant to an initial site of infection or sensitization. Clinical findings typically include an acute, intensely pruritic maculopapular or papulovesicular eruption that most frequently involves the extremities. Histology typically reveals spongiotic dermatitis that often is vesicular, and eosinophils may be present in the infiltrate. Id reactions can result from inflammatory skin conditions such as stasis dermatitis as well as infectious entities including mycobacterial infections. BCG live therapy consists of an attenuated strain of Mycobacterium bovis that is utilized as a first-line treatment of superficial transitional cell carcinomas. We report the case of an id-like reaction in a 90-year-old man who developed an intensely pruritic, scaly, erythematous eruption on all 4 extremities 2 weeks after starting weekly intravesical use of BCG therapy for superficial transitional cell carcinoma. A representative biopsy demonstrated spongiotic dermatitis with overlying scaling and an eosinophilic infiltrate. The eruption resolved after discontinuation of BCG therapy and treatment with topical corticosteroids.

Original languageEnglish (US)
Pages (from-to)145-151
Number of pages7
JournalCutis
Volume91
Issue number3
StatePublished - Mar 1 2013

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Id-like reaction to BCG therapy for bladder cancer'. Together they form a unique fingerprint.

  • Cite this

    Lowther, C., Miedler, J. D., & Cockerell, C. J. (2013). Id-like reaction to BCG therapy for bladder cancer. Cutis, 91(3), 145-151.